Bucephalus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.14 M
as on 09-12-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 44.41%
(FY 2017)
- Profit 25.14%
(FY 2017)
- Ebitda 34.25%
(FY 2017)
- Net Worth 7.25%
(FY 2017)
- Total Assets 14.90%
(FY 2017)
About Bucephalus Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.14 M, as per Ministry of Corporate Affairs (MCA) records.
Savarapu Nihith and Parvathini Aakash serve as directors at the Company.
- CIN/LLPIN
U24232TG2014PTC095262
- Company No.
095262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bucephalus Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savarapu Nihith  | Director | 01-Apr-2023 | Current |
| Parvathini Aakash | Director | 29-Sep-2016 | Current |
Financial Performance of Bucephalus Pharmaceuticals.
Bucephalus Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 44.41% increase. The company also saw a substantial improvement in profitability, with a 25.14% increase in profit. The company's net worth moved up by a moderate rise of 7.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bucephalus Pharmaceuticals?
In 2017, Bucephalus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bucephalus Pharmaceuticals?
Unlock and access historical data on people associated with Bucephalus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bucephalus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bucephalus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
